Injectable Drugs Market Outlook 2024: Global Opportunity And Demand Analysis, Market Forecast, 2016-2024

1. Global America Injectable drugs Market Outlook Global America injectable drugs Market Outlook 2024: Global Opportunity & Growth Analysis, 2016-2024 99 Wall Street, Suite No:- 527, New York, NY 10005 United States of America Office No:- 504, 5th Floor, C-51, BSI Business Park, Sector-62, Noida, PIN:- 201301 India  Report Code :HC 1324 www.goldsteinresearch.com +1-646-568-7747 +1-437-886-1181 +44-203-318-6627 +91-120-473-0422, +91-991-071-6331 sales@goldsteinresearch.com Published By: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

2. Global America Injectable drugs Market Outlook Global America injectable drugs Market Size USD (Billion). 2016-2024 Global America injectable drugs Market Share (%), By Countries -2016-2024 XX% Sample Report CAGR: (2016-2024) Sample Source: Goldstein Research Source: Goldstein Research WithXX%share by 2024, United States will dominate the Global America injectable drugs Market In 2016,Complex Biologics accounted for the highest market share XX% in Global America injectable drugs Market Global America injectable drugs Market Share (%), By Product Type-2016 Global America injectable drugs Market Share (%), By Application -2016 Source: Goldstein Research Source: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

3. Global America injectable drugs Market Outlook • Global America injectable drugs marketis anticipated to reach USD XX billion by 2024 from value USD XX billion in 2016, growing at a CAGR of XX% during the forecast period of 2016 to 2024 owing to rising number of patients affected with chronic disease such as cancer and diabetes • On the basis of market players, in the US, Pfizer leads in sales revenues of about USD XX billion USD in 2013 while Johnson & Johnson realized a revenue of USD XX million USD in 2015. In Switzerland, Novartis made USD XX million in revenues in 2014 while Roche realized USD XX million USD in the same year. In France, Sanofi made USD XX million USD in 2014 while in Japan, Takeda made USD XX million USD in 2014. Bayer in Germany made USD XX million USD in 2014 in pharmaceuticals. • In North America, the most vibrant domestic pharmaceutical market would be found and represents a burgeoning local pharma production industry owing to a protectionist regime as yet. But despite the flourish in local production, the rising consumer demand has led to increasing multinational pharma firms’ interest. Here, the regulatory environment is typified by tough entry barriers largely to protect local industry, price controls, parallel imports and the constant impact of fluctuations in economic conditions • Although much effort has been put into making injectable drug delivery a better experience for patients, the problem remains that most devices are unable to deliver the drug to just the targeted organ and not throughout the whole body. BeloGal, a latest technology which allows drugs to be delivered in high doses to the right organ and avoids the problems of low water solubility that hamper many modern formulations • The drug delivery industry is focused on finding ways to enhance the injection experience, i.e. make it more pleasant for the patient, from helpful reminders, self-use devices, connecting to smartphones, making the syringes larger or smaller and containers gentler and smarter. Healthcare services shifts from clinical settings to the home Medical benefits and reimbursement policies Sample Rise in diabetic population Advancement in pharmaceuticals& cost containment Global America injectable drugs Market Size (USD Billion), By Country, 2016-2024 Year Canada United States 2016 XX Million XX Million XX Million XX Million 2024 Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

4. Global America injectable drugs Market Outlook : 2016-2024 Global America injectable drugs Y-O-Y Growth (%) Analysis-2016-2024 Global America injectable drugs Market Size (USD Billion)-2016-2024 Sample Report Sample Source: Goldstein Research Source: Goldstein Research Table.1. Global Sales (USD Billion) of Injectable Drugs, By Product Type, 2016-2024 Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

5. Fertile Market of Sterile Injectables Sterile Biologics Market Share (%), By Type, 2016 The global sterile Injectable market is USD XX billion in 2016 and is projected to reach USD XX billion by 2024. The two largest segments are Biologics (XX% share) and Small Molecule injectables (XX% share), with a CAGR of XX% for the latter. Within Biologics, monoclonal antibodies (mAbs) account for the largest market share, followed by vaccines and insulin. In the Small Molecule segment, Oncology and Anti-Infectives are the major contributors of the market. Sample Source: Goldstein Research What Is Driving Sterile Injectables Market? Approximately XX injectable products are currently in the development pipeline (potent and non-potent), leading to growth on the innovative side of the market. Demand for cutting edge injectable capabilities should grow as ADCs and other high value products dominate the ‘potent’ development space. Nevertheless, the primary driver behind the growth in injectables is the generic market. Growth in the generic injectables is outpacing growth on the innovator side: The global, generic, sterile injectables market is projected to grow from USD XX billion in 2016 to USD XX billion in 2024 – at a growth rate of XX%. Global America injectable drugs Market Demand-supply Equation The development and manufacturing of sterile injectable products is both, complex, and capital intensive. Operational costs are high since injectables are toxic and infectious in their natural state and hence require a higher degree of quality and care in their manufacturing, packaging, storage, and distribution. Stringent regulations from FDA on manufacturing sites, pose a major challenge for both existing players, and for potential new market entrants. Source: Goldstein Research Competition from low cost manufacturing zones like India and China in the generic market has led to discontinuation of many products in the segment for economies of scale. Consolidation of captive/in-house manufacturing capacities have resulted in closure of many sterile manufacturing sites in the US and elsewhere which, in turn has led to product shortages in the US. Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

6. Global America injectable drugs Market Outlook : 2016-2024 • US Injectable Drugs market accounted for USD XX billion in 2016 which tends to increase at a CAGR of XX% over the forecast years and reach the valuation of USD XX billion by 2024 • The increase focus in biologics and targeted therapies, especially in the area of cancer has led to an increase in the need for injectable drugs. While biological drugs have a larger part of the injectable market, the small molecule injectable will have the higher growth • The complex process of manufacture, high capital and operational costs, and the compliance requirements for success has led to a smaller number of players. These rmsare being further reduced due to acquisitive activity in a sector that is rapidly consolidating. The supply crunch that was present a few years ago has been mitigated to some extent by FDA actions Global America injectable drugs Market Share, By Product Type, 2016-2024 Sample Source: Goldstein Research Global America injectable drugs Market Y-O-Y Growth, By Product Type- 2016-2024 Source: Goldstein Research Global America injectable drugs Market Size (USD Billion), By Application-2016-2024 Source: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

7. Global America injectable drugs Market Attractiveness-By Country, 2016-2024 Global America injectable drugs Market Attractiveness-By Country, 2016-2024 Sample Report CAGR (%) Market Size (USD Billion) Source: Goldstein Research Sample According to the above graph, U.S. Injectable Drugs market is anticipated to be the most attractive market across all the countries in injectable drugs market, for new entrants looking to enter in the market, existing players looking for business expansion and investors seeking investment opportunities over the forecast period i.e. 2016-2024 Canada's single-payer system is mostly publicly funded, while the U.S. has a multi-payer, heavily private system. While dissatisfaction with the U.S. health care system is widespread among Americans, Canada's health care system enjoys high levels of satisfaction among its own population therefore in forecast period Canada tends to reach the considerable market size of injectable drugs United States Canada Download Exclusive Sample Report: https://www.goldsteinresearch.com/request-sample/global-injectable-drugs-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024 Source: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

8. Global America injectable drugs Market Outlook Sample Report About Us Connect With Us: Published By: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

9. Vision Value Visibility About Us Based in U.S., Goldstein Researchis a young business consulting and market research firm with vast reach across America, Asia and parts of Europe and the Middle East. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions. With 30+ domain experts and 50+ employees working day and night to crunch numbers and bring out the best and detailed market reports and forecasts, we strive to enable you to foresee upcoming market challenges and develop a robust business model and strategies, which would add to your profitability and market visibility as a brand. Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Sample Report Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

10. Vision Value Visibility Contact Us: For Research & Sales Related Queries +1-646-568-7747 +1-437-886-1181 +44-203-318-6627 +91-120-473-0422 +91-991-071-6331 sales@goldsteinresearch.com Corporate Office: 99 Wall Street, Suite No:- 527, New York, NY 10005 United States of America Office No:- 504, 5th Floor, C-51, BSI Business Park, Sector-62, Noida, PIN:- 201301 India  www.goldsteinresearch.com Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

11. Global America injectable drugs Market Outlook Sample Report Thank you Connect With Us: Published By: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com